254 related articles for article (PubMed ID: 15845349)
21. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
22. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Wang P; Read M; Sims PF; Hyde JE
Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
[TBL] [Abstract][Full Text] [Related]
23. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
Biswas S
Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
[TBL] [Abstract][Full Text] [Related]
25. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
Cortese JF; Plowe CV
Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
[TBL] [Abstract][Full Text] [Related]
26. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy.
Wang P; Brobey RK; Horii T; Sims PF; Hyde JE
Mol Microbiol; 1999 Jun; 32(6):1254-62. PubMed ID: 10383765
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
28. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
[TBL] [Abstract][Full Text] [Related]
29. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
Le Bras J; Durand R
Fundam Clin Pharmacol; 2003 Apr; 17(2):147-53. PubMed ID: 12667224
[TBL] [Abstract][Full Text] [Related]
30. [Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum from three endemic malaria regions in Colombia].
Galindo JA; Cristiano FA; Knudson A; Nicholls RS; Guerra AP
Biomedica; 2010; 30(1):56-64. PubMed ID: 20890550
[TBL] [Abstract][Full Text] [Related]
31. Molecular assays for surveillance of antifolate-resistant malaria.
Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
[No Abstract] [Full Text] [Related]
32. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
33. Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar.
Contreras CE; Cortese JF; Caraballo A; Plowe CV
Am J Trop Med Hyg; 2002 Oct; 67(4):400-5. PubMed ID: 12452494
[TBL] [Abstract][Full Text] [Related]
34. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA
Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478
[TBL] [Abstract][Full Text] [Related]
35. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
Nirmalan N; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
[TBL] [Abstract][Full Text] [Related]
36. Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension.
Nair S; Brockman A; Paiphun L; Nosten F; Anderson TJ
Int J Parasitol; 2002 Jun; 32(7):852-8. PubMed ID: 12062556
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.
Biswas S; Escalante A; Chaiyaroj S; Angkasekwinai P; Lal AA
Trop Med Int Health; 2000 Oct; 5(10):737-43. PubMed ID: 11044269
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
Siame MN; Mharakurwa S; Chipeta J; Thuma P; Michelo C
Malar J; 2015 May; 14():190. PubMed ID: 25943379
[TBL] [Abstract][Full Text] [Related]
39. Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.
Abdul-Ghani R; Farag HF; Allam AF
Acta Trop; 2013 Feb; 125(2):163-90. PubMed ID: 23131424
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania.
Eberl KJ; Jelinek T; Aida AO; Peyerl-Hoffmann G; Heuschkel C; el Valy AO; Christophel EM
Trop Med Int Health; 2001 Oct; 6(10):756-60. PubMed ID: 11679122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
